Scan_179.pdf
PDF 2 MB Posted
- Solicitation number
- 36C26126Q0728
About this file
This document is a collection of pharmaceutical controlled substance destruction and inventory records for VA Central California's Master Vault-Main Pharmacy located at 2615 E. Clinton Avenue, Fresno, CA 93703.
The primary record is a VA Form 10-2321 Narcotic Dispensing/Receiving Report dated 05/07/2026, documenting the destruction of one broken hydrocodone 5mg/acetaminophen 325mg tablet (Destruction #24317) from Mallinckrodt manufacturing lot 0123K2S300. The document includes corresponding DEA Form 41 reports listing controlled substance destruction activities conducted on 6/4/2026, encompassing 25 different controlled medications across DEA Schedules 2, 3, 4, and 5, including hydrocodone combinations, oxycodone solutions, methadone, methylphenidate, remifentanil, buprenorphine, benzodiazepines (clonazepam, temazepam, lorazepam, chlordiazepoxide, zolpidem), tramadol, and morphine. The inventory records indicate Class 2 medications (hydrocodone, methadone, oxycodone, remifentanil) and Controlled Medications (buprenorphine, benzodiazepines, tramadol) with specific package sizes, counts, and destruction numbers. A DEA Form 222 Official Order Form dated 6/4/2026 documents ordering of multiple pharmaceutical items including acetaminophen-hydrocodone combinations, methadone hydrochloride solutions, methylphenidate, oxycodone solutions, and remifentanil injections from suppliers. All documents contain witness signatures and destruction authorizations as required for controlled substance accountability.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26126Q0728 0001.docx | DOCX document | |
| 36C26126Q0728_1.docx | DOCX document | |
| Past Performance Survey.pdf | ||
| Fresno WD.pdf | ||
| VA Directive 1114_D_2021-01-11.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
VA FORM 10-2321 Narcotic Dispensing/Receiving Report for MASTER VAULT-MAIN PHARMACY Page: 1
05/07/2026
DATE DATE
DISP # DISPENSED QTY DRUG ORD ORDERED BY
Destruction # 24317
05/07/2026 (~) Witnessed by:
(Full Name)
5MG/ACETANINOpHEN
Witnessed by:•
(Full Name)
COMMENTS: broken tab mfg:Mallinckrodt lotOl23K2S300 ndcO4OG-0l23-0l jt~
~AA~
HOLD # DRUG
DESTROYED CS DRUGS REPORT for DEA FORM 41 Dispensing Site: MASTER VAULT-MAIN PHARMACY Printed: JUN 4,2026
# OF
PAGE: 1
CONT QTY UNIT
u~ L~4~C-~ ~
24317 24318 243194” 24320 4’ 24321 4~ 24322 4~ 24323 24324 —
24325 24326 24327 24328 4, 24329 ~ 24330 243314;
24332 1 24333 243 34 2433 54~.
2433 6,~ 24337 24338 24339~4 24340 4, 24341 4, I
4r ~ 4_%L;.:-\
Date:
Destroyed By:
A
Witnessed By:
Witnessed By: •.. ~_-
HYDROCODONE 5MG/ACETRMINOPHEN 325MG TAB
HYDROCODONE 10/ACETABINOPHEN 325MG TAB
METHYLPHENIDATE 10MG TAB UD
OXYC000NE CONC 2OMG/ML SOLN 1ML UD
BUPRENORPHINE 2MG TAB,SUBLINGUAL
REMIFENTANIL HCL 2MG/VIL INJ
REMIFENTANIL HCL 1MG/VIL INJ
XNF CLONAZEPAM (BRAND) 1MG TAB
TEMAZEPAM 15MG CAP
OXYCODONE CONCENTRATED 2OMG/ML SOLN
METHADONE HCL 2MG/ML SOL ORAL, 5ML UD
METHADONE HCL 2MG/ML SOL,ORAL,25ML UD
TRAMADOL HCL 50MG TAB * CS *
HYDROCODONE 10/ACETAMIMOPHEN 325MG TAB
HYDROCODONE 10/ACETAMINOPHEN 325MG TAB
BUPRENORPHINE 2MG/NALOXONE 0.5MG SL TAB
BUPRENORPHINE 8MG/NALOXONE 2MG SL TAB
XNF LORAZEPAM 2MG/ML ORAL CONC UD,1ML
CHLORDIAZEPOXIDE 25MG CAP UD
LORAZEPAM INJ 2MG/ML,1ML
ZOLPIDEM TARTRATE 6.25MG SA TAB DO
LORAZEPAM INJ 2MG/ML,1ML
BUPRENORPHINE 2MG TAB,SUBLINGUAL
METHYLPHENIDATE 5MG TAB
MORPHINE S04 1MG/ML SOLN INJ PCA,3OML
1 1 tab 1 1 tab 1 10 tab 1 1 syr
1 1 TAB
1 1 VIAL
1 1 VIAL
1 81 TAB
1 40 CAP
1 3 ML
5 5 SYRINGE
6 6 SYRINGE
1 .5 tab
1 2 TAB
1 3 tab
2. 1 TAB
1 1 tab
1 5 syr
1 13 TAB
1 2 carpuject 1 ,2 tab
1 1 vial
1 2 TAB
1 1 tab 1 10 poe
END OF REPORT!!
Customer Info VA Central California
2615 E. Clinton Ave~ Fresno, CA 93703
Wholesaler None Provided
PkgVS~ze
•V~V•100VV
100 V V
10o~
1V
3V•
500 ml
500 ml 150
3OMIV
3cYMl
(559)225-6100
VDEA Number WholesalèrA~xt#
Class 2 Medication Inventory
NDC DEA Med Name Manufacturer Class f V
0406012501 2 ACETAM1NOPHEN-HYDROCODONE BITARTRAT TAB- 325 MG- SpecGX
0406012501 2 ACETAMINOPHEN-HYDROCODONE BITARTRAT TAB- 325 MG SpecGX
0406012501 2 ACETAMINOPHEN-HYDROCODONE BITARTRAT TAB- 325 MG- SpecGX
0406012301 2 ACETAM I NO P H EN-HYDROCODON E BITARTRAT TAB- 325 MG- SpecGX
0054355663 2 METHADONE HCLSOL- 10 MG/S ML Roxane
0054355663 2 METHADONE HCL SOl- 10 MG/5 ML Roxane
0406114401 2 METHYIPHENIDATE HYDROCHLOi~lDE TAB- 10 MG SpecGX
0406114201 2 METHYLPHENIDATE HYDROCHLORIDE TAB-S MG SpecGX
7632919121 2 Morphine 1r~g/rnL
0406855730 2 OXYCODONE HYDROCHLORIDE ORAL SOL- 100 MG/S ML (20 SpecGX
0406855730 2 OXYCODONE HYDROCHLORIDE ORAL-SOL- 100 MG/ S ML (20 SpecGX
6332372303 2 REMIFENTANIL HCL INJ- 1 MG Fresenius
6332372405 V 2 REMIEENThNIL HCL INJ 2MG .FrëseniusV
Count Destruction #
•~4~V~8
V24330
V 24331 24317
V 24327 V
24328 VV V VV~ V V V
V 24319. V S V
2434O~ V
24341J
V 24320 V V
V VV V V
V ~: V24~22 V V
0641600101.
04068b2003 0406800503 7288818230
.7~88818230~ ~.510~914i01 :6126961010 0409198503 01210770Q1 0406996101.
5140700701 6818077904
Full .:~. Partial Destru~tion # Packages Count .~
1 24338 24333
*0 :* ~ -.24~32*~ 0 .1 ~:243.21...
0. :..~::* .24339 p ~ 24.335~H:
~ ~ .24324.:
~ 24336 0 5 24334
4ó 243~.
0.5 24329 .2 24337
Customer info VA Central California . . . . Wholes~ier None Provided ~ . 2615 E. ClintohAve .
. Fresno, CA 93703 .
(559) 225-6100 Wholesaier Acct 4~
DEA Number
Controlled Medication Inventory
NDC ~ DEA
Class
Pkg Size
~0.
30~
.30.
1::
10O~
..-1.00
Med Name. . Manufácturei
4 ATIVAN SOL- 2 MG/ML West-Ward 3 BUPRENORPHINE AND NALOXONE SUBLINGUALTAB- SpecGX 3 Buprenorphine and Naloxone Sublingual Tabs 2mgfO 5 3 Buprenorphine Sublingual Tabs 2mg 3 Buprenorphine Sublingual Tabs 2mg 4 CHLORDIAZEPOXIDE HCL CAP- 25 MG Mylan Institutional 5 Clonazep~m 1mg Tab 4 Lorazepam injection 2mg/mL 4 LORAZEPAM SOL- 2 MG/ML Pharm Assoc Inc 4 Temazepam Cap 15mg 4 Tramadol Hydrochloride Tabs USP 50mg 4 ZolpidèmTattrate~6.25rng.Tab . -- . . . - . . .,.
Page lof 1
0~
DEA FORM-222 U.S. OFFICIAL ORDER FORMS - SCHEDULES I & II
DRUG ENFORCEMENT ADMINISTRATION
PURCHASER INFORMATION REGISTRATION INFORMATION SUPPLIER DEA NUMBER:# I I I I I I I I I
, — - I~_, • . ~ I I I I I
REGISTF ‘~9)N ~ PART 2: TO BE FILLED IN BY PURCHASER
REGISThR~D AS: ~1A C~ntr~1 CaIifprn~a~
5~SCHED1JLES: 2,2N,3,3N,4,5, BUSINESS NAME
ORDER FORM NUMBEF 2615 F. Clinton Ave.
DATE ISSUED STREET ADDRESS
~ ORDERFORM ~e~nc,CA937~
CITY, STATE, ~ZIP CODE
PART 1: TO BE FILLED IN BY PURCHASER PART 3: ALTERNATE SUPPLIER IDENTIFICATION - to be filled in by first supplier
~ PART 5~ (name in part 2) if order is endorsed to another supplier to fill.
~ TOBE ALTERNATEDEA#
~~ FILLED IN BY
~J PIJRCKASER Signature- byirst supplier .. ... 6/4/2026
Signature of Requesting Official ~i~’ust be authorized to sign order form) Date
— OFFICIAL AuTHORIZED TO EXECUTE ON BEHALF OF SUPPLIER DATE rr~tvi NO. OF PACKAGE NAME OF ITEM NUMBER] DATE PART 4: TO BE FILLED IN BY SUPPLIER NUMBER DATEPACKAGES SIZE RECD RECD NATIONAL DRUG CODE SHIPPED SHIPPED
1. i/10L. .~ A~TAMt~PHEN~ll~QQQNF BITARtRAT TAR- 325 MG-iOt~ I____ ~ O~ 0 G~- 0- 1~ ~ ~ ~‘-4~ 2t~ 1 i,L1OIL_ ACErAMINOP~DRn€ODQ~ITARTRATTAB-325 MG-1ê~- 0 .4_ ..Q. ~ 2.. ~ 2. I t~
-._ /100..2.~TAB-~ o~ a- 4 0 &- 0~ ~ 2 £ c~ i~ ~— ,~-. /100~ ~ ~ s~oizs~~ :~- - ... .- .~ ~ ~ ~- Co ‘4’ Z(~
..._1__ 5L~iQ0_~ ..~ G~ 0 5 4~- 3 5- 5 & 6. 3: 1
~ L_ Q~0Q. M~HYLPHENIQA~E~1V~CKLORIDE TA~ 1OM~ ~ -Q~ ~ ~ ~ ~_ ‘ ~. ~ 24’
,.. I1OQ . MTH?LP~IE~IpA1E ~WD~CKLORIDE TAB~ SM~~ Q~ Q~ 4 0 ~ 1 1 4- 2 (~ t 1: (p . (~ ~9’
4- ~0Q/3O - - ,,,. / 0-- ‘6 3 -~ 9 1 -~ 2 1 ao 1 ~/30 OXYCODONE HY~~~LO~IDE ORAL SOL- 100 MGI 5 ML (20’M~R~)-- I_____ L ..4_ iL L ~ ~ . i-f. ~
5 ML (2O-~f~ S.
~ ./1 REMIFEN.TAN~L F~1~-1MG ~ -1- 2~ ~ I (~ •~‘
~ 1 .— -~•.•- .-~.• ~ a i
~, S -: - ... S.-
~ +~LAST LINE COMPLETED (MUST BE 20 OR LESS)
File details come from the government source that posted it. Updated .